These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 26465832)
21. A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Talaei A; Hosseini FF; Aghili Z; Akhondzadeh S; Asadpour E; Mehramiz NJ; Forouzanfar F Can J Physiol Pharmacol; 2020 Apr; 98(4):236-242. PubMed ID: 32228235 [TBL] [Abstract][Full Text] [Related]
22. Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia. Dwivedi S; Pavuluri M; Heidenreich J; Wright T J Child Adolesc Psychopharmacol; 2002; 12(1):69-70. PubMed ID: 12014598 [No Abstract] [Full Text] [Related]
23. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. Stein DJ; Bouwer C; Hawkridge S; Emsley RA J Clin Psychiatry; 1997 Mar; 58(3):119-22. PubMed ID: 9108814 [TBL] [Abstract][Full Text] [Related]
24. Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. Fitzgerald KD; Stewart CM; Tawile V; Rosenberg DR J Child Adolesc Psychopharmacol; 1999; 9(2):115-23. PubMed ID: 10461822 [TBL] [Abstract][Full Text] [Related]
25. Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report. Uzun O J Psychopharmacol; 2010 Mar; 24(3):425-7. PubMed ID: 19010977 [TBL] [Abstract][Full Text] [Related]
26. Antiobsessional effect of risperidone add-on treatment in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder may be dose-dependent. Ramasubbu R Arch Gen Psychiatry; 2002 May; 59(5):472; author reply 472-3. PubMed ID: 11982460 [No Abstract] [Full Text] [Related]
27. A review of antipsychotics in the treatment of obsessive compulsive disorder. Fineberg NA; Gale TM; Sivakumaran T J Psychopharmacol; 2006 Jan; 20(1):97-103. PubMed ID: 16204331 [No Abstract] [Full Text] [Related]
28. Effect of Ziprasidone Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: A 12-Week, Open-Label Uncontrolled Preliminary Study. Bruno A; Pandolfo G; Cedro C; Gallo G; De Felice M; Zoccali RA; Muscatello MR Clin Neuropharmacol; 2016; 39(1):6-9. PubMed ID: 26757309 [TBL] [Abstract][Full Text] [Related]
29. Pharmacotherapy of obsessive-compulsive disorder: experience with the selective serotonin reuptake inhibitors. Vythilingum B; Cartwright C; Hollander E Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S7-13. PubMed ID: 11110014 [TBL] [Abstract][Full Text] [Related]
30. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder. Mohr N; Vythilingum B; Emsley RA; Stein DJ Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505 [TBL] [Abstract][Full Text] [Related]
31. Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood. Akyol Ardic U; Ercan ES; Kutlu A; Yuce D; Ipci M; Inci SB Child Psychiatry Hum Dev; 2017 Oct; 48(5):699-704. PubMed ID: 27812841 [TBL] [Abstract][Full Text] [Related]
32. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. Barbosa L; Berk M; Vorster M J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240 [TBL] [Abstract][Full Text] [Related]
37. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069 [TBL] [Abstract][Full Text] [Related]
38. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder. Hollander E; Dell'Osso B Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143 [TBL] [Abstract][Full Text] [Related]
39. Use of the selective serotonin reuptake inhibitor citalopram in a possible animal analogue of obsessive-compulsive disorder. Stein DJ; Mendelsohn I; Potocnik F; Van Kradenberg J; Wessels C Depress Anxiety; 1998; 8(1):39-42. PubMed ID: 9750979 [TBL] [Abstract][Full Text] [Related]
40. Follow-up of obsessive-compulsive patients treated with proserotonergic agents. Mundo E; Erzegovesi S; Bellodi L J Clin Psychopharmacol; 1995 Aug; 15(4):288-9. PubMed ID: 7593716 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]